Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
Sales: $22.4 Billion Headcount: 12,000 Revenues: $22,449 (+1%) Net Income: $5,364 (-2%) R&D: $9,106 (+81%) TOP SELLING DRUGS Despite a relatively flat fiscal year, Gilead continues to make pipeline progress, along with efforts to diversify its portfolio, and further expand into immuno-oncology with significant investments, namely the acquisition of Forty Seven and an extensive alliance with Arcus Biosciences
Has L-Carnitine actually been proven to improve stallion fertility
GLP-1 dinners for people who exercise If you are combining GLP-1 therapy with resistance training (which you should be), dinner timing relative to your workout matters
The observed weight loss among patients led many people to try the drug off-label, sparking global supply chain problems
doi: 10.3389/fimmu.2025.1690068 Received 21 August 2025 Accepted 03 October 2025 Published 16 October 2025 Volume 16 - 2025 Edited by Adil Rasheed, Augusta University, United States Reviewed by Zhi-Wei Wang, Wenzhou Medical University, China Yang Xiang, Peking Union Medical College Hospital (CAMS), China Updates Copyright 2025 Yang, Li, Shi, Zhong and Xiong
